The latest Business updates from the science industry
by Heather Hobbs
LTE Scientific Assists Frontline Fight against Covid-19 and Prepares for Significant Growth
LTE Scientifi c has risen to an unprecedented challenge to assist in the frontline fi ght against Covid-19 as well as forging ahead with ambitious growth and redevelopment plans amid the global pandemic.
LTE Scientifi c specialises in the manufacture, supply and service / testing of medical and laboratory equipment including autoclaves, medical sterilisers, endoscope drying/storage and decontamination solutions plus a wide range of laboratory thermal equipment.
LTE recently carried out an incredible two-day turnaround to supply and install a specialist autoclave to allow the urgent commencement of Covid-19 testing at a laboratory in Alderley Park, Cheshire.
It has kept up with demand and production throughout the virus outbreak to enable it to continue to supply its essential equipment and service to healthcare providers and laboratories across the UK.
LTE is pushing forward with its investment and expansion plans to ensure it continues to be an international market leader.
This is refl ected in the announcement of a number of key internal promotions across all departments and on-going investment in training and recruitment.
Externally LTE has appointed Zoe Turner as Operations Manager to oversee its quality department. Zoe brings over 20 years of experience in manufacturing works and operations management to her new role at LTE.
Alison Fox has been promoted to Production Planning Manager, replacing Sarah Gill, who retires at the end of June.
A new Service Management Team (SMT) has been created to further develop the rapid service growth experienced by LTE.
Steve Neville has been promoted to Field Service Manager on the back of his 19 years’ experience in supporting clients across the country as a Senior Field Service Engineer.
Other SMT members include Alice Higginbottom, who will continue in her role as Service Administration Manager and Lee Kershaw is continuing in his role as Technical Support Manager.
Danny Brear will join the SMT, taking on the role of deputy UKAS Technical Manager who will be responsible for software developments on products, reporting, and assisting with UKAS.
Also joining the SMT is Adam Pugh who will continue his Senior Engineer Role while taking on LTE’s product specialist position to oversee third party product knowledge.
Darren Bottomley has taken over the role of Sales Manager with responsibility of coordinating the sales offi ce, UK sales team and export team.
Sarah Clegg will become Finance Manager, with responsibility for the preparation of monthly management accounts, in addition to her current IT and human resources management roles.
John Lees, Managing Director at LTE Scientifi c, said: “We want to congratulate everyone involved in these latest appointments, thank our long-serving staff for their contributions over many years and welcome our new Operations Manager, Zoe.
“Thanks to an extremely strong order book we have remained fully operational throughout the coronavirus pandemic in continuing to supply essential equipment and service to laboratories and healthcare providers.
“We are extremely proud of our team’s resilience and dedicated performance during this uncertain time. Staff have followed coronavirus safety guidelines while continuing to operate highly effi ciently and professionally.”
More information online:
ilmt.co/PL/emDG
LTE Scientifi c’s Managing Director, John Lees with the Touchclave R Autoclave installed to assist Covid-19 testing programme at a laboratory in Alderley Park, Cheshire.
52662pr@reply-direct.com
Competitors form Joint Business Venture
Applied Photophysics (APP) and Fluorescence Innovations (FI) have entered into a joint venture agreement to develop and produce protein stability systems for leading researchers and industries around the globe.
The two fi rms said they will be equal partners in the new initiative. The joint venture will be autonomous and independent, with APP and FI continuing to compete in all other business areas, the companies said. They anticipate that joining forces on protein stability systems will lower development costs and bring forward a cutting-edge technology centered around a chemical melt protein stability system.
“With the development of biopharmaceuticals comes the need for discovery tools and new analysis tools to ensure the safety of product and ability to get the products to the patient in a timely, safe and user-friendly manner,” said Tim Flanagan, CEO of the newly-founded Protein Stable Ltd.
Both companies aim to offer their specifi c expertise with FI handling the development of the technology and APP offering streamlined sales and manufacturing support to produce the system. Each business has signifi cantly played a vital role in the success of Protein Stable.
52833pr@reply-direct.com
Team Strengthened ahead of Commercialisation Phase
Respiratory pharmaceutical company Senzer has expanded its Board and reshaped its executive team under changes aimed at bolstering its commercialisation strategy for COVID-19 and cannabinoid treatments.
Senzer’s new chairman, Barbara Staehelin, is a serial entrepreneur who founded four life science companies and has had an executive role with Roche Diagnostics. She will be joined on the board by non-executive directors, Tim Corn, CMO at Izana Bioscience and Andy Weymann who served as CMO to Smith and Nephew.
Former CEO Alex Hearn, founder and inventor of the inhalation platform at the heart of the Company, will remain actively involved in the business as Deputy Chairman and will continue to assist the Company on scientifi c and technical strategy. Adam Kelliher, who has been involved with the company for more than two years as Chairman and Executive Chairman, has strong commercialisation expertise and becomes CEO.
Qualifi ed doctor Matt McKevitt has been promoted to COO and Dr Andrew Saich, previously International Medical Director at GW Pharmaceuticals, will become CMO. Wendy Lloyd-Goodwin, previously head of legal and compliance at Bristol Myers Squibb (UK. EIR) will be Senzer’s General Counsel. They will join the executive team with Chief Financial Offi cer (CFO) Nick Robbins-Cherry, who has more than 25 years’ experience in US and UK public markets.
“We now have in place a highly experienced executive team and a very focused Board. These appointments are crucial as our unique respiratory offerings will soon be ready for patients and users, We
Barbara Staehelin
all owe so much to Alex Hearn, under whose leadership Senzer has developed a remarkable product pipeline that enables us to now take the company into a commercial execution phase,” said Adam Kelliher.
52829pr@reply-direct.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
